Analyze DCF forecasts for the company and compare them with competitors.
1.37T
Revenue has increased from the previous period.
9.07%
Revenue growth rate is unchanged from the previous period.
81.80B
EBITDA has increased from the previous period.
5.99%
EBITDA margin is unchanged from the previous period.
54.37B
EBIT has increased from the previous period.
3.98%
EBIT margin is unchanged from the previous period.
27.43B
Depreciation has increased from the previous period.
84.99B
Total cash has increased from the previous period.
6.22%
Cash percentage is unchanged from the previous period.
3.75B
Receivables have increased from the previous period.
0.27%
Receivables percentage is unchanged from the previous period.
118.10B
Inventories have increased from the previous period.
8.65%
Inventory percentage is unchanged from the previous period.
259.09B
Accounts payable has increased from the previous period.
18.97%
Payables percentage is unchanged from the previous period.
-67.07B
Capital expenditure has increased from the previous period.
-4.91%
CapEx percentage is unchanged from the previous period.
5.07%
WACC is unchanged from the previous period.
5.18%
Cost of equity is unchanged from the previous period.
3.99%
Cost of debt is unchanged from the previous period.
0.25
Beta is unchanged from the previous period.
79.24M
Diluted shares outstanding is unchanged from the previous period.
34.06B
Total debt is unchanged from the previous period.
696.60B
Total equity is unchanged from the previous period.
730.66B
Total capital is unchanged from the previous period.
4.66%
Debt weighting is unchanged from the previous period.
95.34%
Equity weighting is unchanged from the previous period.
38.72B
EBIAT has increased from the previous period.
10.49B
UFCF has increased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
379.47B
Terminal value is unchanged from the previous period.
352.79B
Enterprise value is unchanged from the previous period.
-18.24B
Net debt is unchanged from the previous period.
371.03B
Equity value is unchanged from the previous period.
4682.41
Equity value per share is unchanged from the previous period.
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Analyze analyst forecasts for the company and compare them with competitors.
1169.12B
The estimated revenue has increased from the previous period.
70.02B
The estimated EBITDA has increased from the previous period.
436.77
The estimated EPS has increased from the previous period.
34.39B
The estimated net income has increased from the previous period.
46.54B
The estimated EBIT has increased from the previous period.
165.43B
The estimated SG&A expenses have increased from the previous period.
